RISK OF MORTALITY IN PATIENTS RECEIVING HIGH-VOLUME ONLINE HEMODIAFILTRATION (OL-HDF) VERSUS HIGH-FLOW HEMODIALYSIS (HD) THERAPY IN 14 FRESENIUS MEDICAL CARE ECUADOR (FMC) CLINICS.

https://storage.unitedwebnetwork.com/files/1099/73fd03e9453048bffc39e3c17f5c878e.pdf
RISK OF MORTALITY IN PATIENTS RECEIVING HIGH-VOLUME ONLINE HEMODIAFILTRATION (OL-HDF) VERSUS HIGH-FLOW HEMODIALYSIS (HD) THERAPY IN 14 FRESENIUS MEDICAL CARE ECUADOR (FMC) CLINICS.
GABRIELA VANESSA
TAMAYO ALBÁN
Jorge Oswaldo Quinchuela Hidalgo jorge.quinchuela@fmc.com.ec FRESENIUS MEDICAL CARE ECUADOR MEDICAL QUITO
Jadira Natalia Benavides Altamirano natalia.benavides@fmc-ag.com FRESENIUS MEDICAL CARE ECUADOR MEDICAL QUITO